Table 1 Patient baseline characteristics and in‐hospital management of the total cohort of patients admitted within 12 h of onset of symptoms (n = 1204).
| Characteristic | Direct admission to CCU | Admission via ER | p Value |
|---|---|---|---|
| n = 806 (66.9%) | n = 398 (33.1%) | ||
| Age (years)* | 64.1 (14) | 64.6 (15) | 0.56 |
| Age ⩾70 years | 309 (38.3%) | 175 (44.0%) | 0.06 |
| Sex (female) | 194 (24.1%) | 120 (30.2%) | 0.025 |
| Hypertension | 350 (43.4%) | 180 (45.2) | 0.55 |
| Diabetes | 155(19.2%) | 78 (19.6%) | 0.88 |
| Hypercholesterolaemia | 327 (41.3%) | 159 (40.3%) | 0.72 |
| Current smoker | 301 (37.4%) | 131 (33.2%) | 0.15 |
| History of myocardial infarction | 115 (14.3%) | 65 (16.3%) | 0.34 |
| History of congestive heart failure | 35 (4.3%) | 19 (4.8%) | 0.72 |
| History of stroke | 30 (3.7%) | 21 (5.3%) | 0.20 |
| History of CABG | 25 (3.1%) | 14 (3.5%) | 0.70 |
| Previous PCI | 63 (7.9%) | 32 (8.0%) | 0.91 |
| Peripheral artery disease | 58 (7.2%) | 34 (8.6%) | 0.41 |
| Renal insufficiency | 27 (3.4%) | 21 (5.3%) | 0.10 |
| Anterior infarct | 292 (36.3%) | 162 (40.8%) | 0.13 |
| Killip class at admission | 0.01 | ||
| Missing | 3 | 0 | |
| I | 659 (82.1%) | 305 (76.6%) | |
| II–III | 124 (15.4%) | 88 (22.1%) | |
| IV | 20 (2.5%) | 5 (1.3%) | |
| TIMI risk score* | |||
| All patients | 3.1 (2.3) | 3.5 (2.6) | 0.03 |
| Excluding patients with prehospital lysis | 3.3 (2.4) | 3.5 (2.6) | 0.11 |
| Medical treatment 48 h after admission | |||
| Oral antiplatelet agents | 772 (95.8%) | 377 (94.7%) | 0.41 |
| Glycoprotein IIb/IIIa inhibitors | 194 (24.1%) | 55 (15.5%) | 0.001 |
| β blockers | 608 (75.4%) | 288 (72.4%) | 0.25 |
| ACE inhibitors | 323 (40.1%) | 157 (39.4%) | 0.83 |
| Intravenous inotropes | 42 (5.2%) | 26 (6.5%) | 0.35 |
| Statins | 405 (50.2%) | 163 (41.0%) | 0.002 |
| In‐hospital use of angiography/revascularisation | |||
| Coronary angiography | 686 (85.1%) | 301 (75.6%) | <0.001 |
| PCI at any time during hospital stay (including primary PCI) | 554 (69.9%) | 212 (55.6%) | <0.001 |
| PCI (after first 24 h) | 182 (23.0%) | 107 (28.1%) | 0.06 |
| CABG | 15 (1.9%) | 15 (3.8%) | <0.05 |
Data are number (%) unless otherwise indicated.
*Data presented as mean (SE).
ACE, angiotensin‐converting enzyme; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CCU, coronary care unit; ER, emergency room; PCI, percutaneous coronary intervention; TIMI, Thrombolysis in Myocardial Infarction.